Christopher Reading

Christopher Reading

Hoofd Techniek/Wetenschap/O&O bij
Harbor Therapeutics, Inc.
78 jaar
Consumer Services
Health Technology
Health Services

Profiel

Christopher L.
Reading
is currently the Chief Scientific Officer at Harbor Therapeutics, Inc. He previously held positions as Vice President-Product & Process Development at Systemix, Inc. and Novartis, Inc. He also served as Chief Scientific Officer at Harbor Diversified, Inc. and was an Associate & Assistant Professor at The University of Texas M.D.
Anderson Cancer Center.
Reading holds a doctorate from the University of California, Berkeley and an undergraduate degree from the University of California San Diego.

Actieve functies van Christopher Reading

BedrijvenFunctieBegin
Hoofd Techniek/Wetenschap/O&O 01-01-1999

Eerdere bekende functies van Christopher Reading

BedrijvenFunctieEinde
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
HARBOR DIVERSIFIED, INC. Hoofd Techniek/Wetenschap/O&O -
Ervaring van Christopher Reading in detail bekijken

Opleiding van Christopher Reading

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

1

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Christopher Reading